To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Esketamine–Dexmedetomidine and Early Cognitive Function After Lumbar Surgery in Elderly

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
April 2025

Esketamine–Dexmedetomidine and Early Cognitive Function After Lumbar Surgery in Elderly

Vol: 307| Issue: 4| Number:57| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Effects of Esketamine Combined with Dexmedetomidine on Early Postoperative Cognitive Function in Elderly Patients Undergoing Lumbar Spinal Surgery: A Double-Blind Randomized Controlled Clinical Trial.

Drug Des Devel Ther . 2024 Nov 27:18:5461-5472.

Contributing Authors:
QY Tao D Liu SJ Wang X Wang RN Ouyang JY Niu R Ning JM Yu

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

One hundred fifty-nine elderly patients undergoing lumbar spine surgery were randomized to receive esketamine plus dexmedetomidine (ED group, n=53), esketamine alone (E group, n=53), or dexmedetomidine alone (D group, n=53). The primary outcome was the incidence of postoperative cognitive dysfunction (POCD) on the first postoperative day. Secondary outcomes included POCD on the third day, serum ne...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue